{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T10:02:30Z","timestamp":1774605750211,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["ME9870\/320030-153389 and 31BL30_185396"],"award-info":[{"award-number":["ME9870\/320030-153389 and 31BL30_185396"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CANSEARCH Foundation"},{"DOI":"10.13039\/100001275","name":"OAK Foundation","doi-asserted-by":"crossref","award":["OCAY-17-642"],"award-info":[{"award-number":["OCAY-17-642"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-39624-y","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T19:35:10Z","timestamp":1771875310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Busulfan resistance in AML is associated with changes in mitochondrial copy number and lipid metabolism"],"prefix":"10.1038","volume":"16","author":[{"given":"Vid","family":"Mlakar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Jurkovi\u0107 Mlakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Gloor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Dupanloup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoann","family":"Sarmiento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Boudal-Khosbheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chakradhara Rao Satyanarayana","family":"Uppugunduri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"39624_CR1","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3390\/ph16111614","volume":"16","author":"S Tseng","year":"2023","unstructured":"Tseng, S., Lee, M. E. & Lin, P. C. A review of childhood acute myeloid leukemia: Diagnosis and novel treatment. Pharm. Basel 16, 1614. https:\/\/doi.org\/10.3390\/ph16111614 (2023).","journal-title":"Pharm. Basel"},{"key":"39624_CR2","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1038\/s41375-025-02685-5","volume":"39","author":"E Rettinger","year":"2025","unstructured":"Rettinger, E. et al. The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemia. Leukemia 39, 2313\u20132328. https:\/\/doi.org\/10.1038\/s41375-025-02685-5 (2025).","journal-title":"Leukemia"},{"key":"39624_CR3","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/j.leukres.2008.01.016","volume":"32","author":"BC Valdez","year":"2008","unstructured":"Valdez, B. C. et al. Altered gene expression in busulfan-resistant human myeloid leukemia. Leuk. Res. 32, 1684\u20131697. https:\/\/doi.org\/10.1016\/j.leukres.2008.01.016 (2008).","journal-title":"Leuk. Res."},{"key":"39624_CR4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.bbmt.2008.12.489","volume":"15","author":"SO Ciurea","year":"2009","unstructured":"Ciurea, S. O. & Andersson, B. S. Busulfan in hematopoietic stem cell transplantation. Biol. Blood Marrow. Transplant. 15, 523\u2013536. https:\/\/doi.org\/10.1016\/j.bbmt.2008.12.489 (2009).","journal-title":"Biol. Blood Marrow. Transplant."},{"key":"39624_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/bmt.2009.143","volume":"45","author":"M Ansari","year":"2010","unstructured":"Ansari, M. et al. Influence of GST gene polymorphisms on busulfan pharmacokinetics in children. Bone Marrow. Transplant. 45, 261\u2013267. https:\/\/doi.org\/10.1038\/bmt.2009.143 (2010).","journal-title":"Bone Marrow. Transplant."},{"key":"39624_CR6","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1182\/blood-2013-07-514448","volume":"122","author":"EA Copelan","year":"2013","unstructured":"Copelan, E. A. et al. Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. Blood 122, 3863\u20133870. https:\/\/doi.org\/10.1182\/blood-2013-07-514448 (2013).","journal-title":"Blood"},{"key":"39624_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1476-4598-1-9","volume":"1","author":"JS Carew","year":"2002","unstructured":"Carew, J. S. & Huang, P. Mitochondrial defects in cancer. Mol. Cancer 1, 9. https:\/\/doi.org\/10.1186\/1476-4598-1-9 (2002).","journal-title":"Mol. Cancer"},{"key":"39624_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-018-0011-z","volume":"3","author":"X Sun","year":"2018","unstructured":"Sun, X. et al. Increased mtDNA copy number promotes cancer progression by enhancing mitochondrial oxidative phosphorylation in microsatellite-stable colorectal cancer. Signal Transduct. Target. Ther. 3, 8. https:\/\/doi.org\/10.1038\/s41392-018-0011-z (2018).","journal-title":"Signal Transduct. Target. Ther."},{"key":"39624_CR9","doi-asserted-by":"publisher","first-page":"e1710","DOI":"10.1038\/cddis.2015.78","volume":"6","author":"H Mei","year":"2015","unstructured":"Mei, H. et al. Reduced mtDNA copy number increases the sensitivity of tumor cells to chemotherapeutic drugs. Cell Death Dis. 6, e1710. https:\/\/doi.org\/10.1038\/cddis.2015.78 (2015).","journal-title":"Cell Death Dis."},{"key":"39624_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41588-019-0557-x","volume":"52","author":"Y Yuan","year":"2020","unstructured":"Yuan, Y. et al. Comprehensive molecular characterization of mitochondrial genomes in human cancers. Nat. Genet. 52, 342\u2013352. https:\/\/doi.org\/10.1038\/s41588-019-0557-x (2020).","journal-title":"Nat. Genet."},{"key":"39624_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.mito.2021.03.013","volume":"58","author":"S Chaudhary","year":"2021","unstructured":"Chaudhary, S. et al. PGC1A driven enhanced mitochondrial DNA copy number predicts outcome in pediatric acute myeloid leukemia. Mitochondrion 58, 246\u2013254. https:\/\/doi.org\/10.1016\/j.mito.2021.03.013 (2021).","journal-title":"Mitochondrion"},{"key":"39624_CR12","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1124\/jpet.111.179473","volume":"337","author":"K Hara","year":"2011","unstructured":"Hara, K. et al. Mitochondria determine the efficacy of anticancer agents that interact with DNA but not the cytoskeleton. J. Pharmacol. Exp. Ther. 337, 838\u2013845. https:\/\/doi.org\/10.1124\/jpet.111.179473 (2011).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"39624_CR13","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s10495-017-1424-9","volume":"22","author":"Z Zou","year":"2017","unstructured":"Zou, Z., Chang, H., Li, H. & Wang, S. Induction of reactive oxygen species: An emerging approach for cancer therapy. Apoptosis 22, 1321\u20131335. https:\/\/doi.org\/10.1007\/s10495-017-1424-9 (2017).","journal-title":"Apoptosis"},{"key":"39624_CR14","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1186\/s12885-019-6438-y","volume":"19","author":"T Zaidieh","year":"2019","unstructured":"Zaidieh, T., Smith, J. R., Ball, K. E. & An, Q. ROS as a novel indicator to predict anticancer drug efficacy. BMC Cancer 19, 1224. https:\/\/doi.org\/10.1186\/s12885-019-6438-y (2019).","journal-title":"BMC Cancer"},{"key":"39624_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00432-021-03769-2","volume":"148","author":"S Jurkovic Mlakar","year":"2022","unstructured":"Jurkovic Mlakar, S. et al. GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation. J. Cancer Res. Clin. Oncol. 148, 71\u201386. https:\/\/doi.org\/10.1007\/s00432-021-03769-2 (2022).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"39624_CR16","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41419-019-1851-3","volume":"10","author":"SB Panina","year":"2019","unstructured":"Panina, S. B., Baran, N., Brasil da Costa, F. H., Konopleva, M. & Kirienko, N. V. A mechanism for increased sensitivity of acute myeloid leukemia to mitotoxic drugs. Cell Death Dis. 10, 617. https:\/\/doi.org\/10.1038\/s41419-019-1851-3 (2019).","journal-title":"Cell Death Dis."},{"key":"39624_CR17","doi-asserted-by":"publisher","first-page":"1244280","DOI":"10.3389\/fonc.2023.1244280","volume":"13","author":"L Feng","year":"2023","unstructured":"Feng, L., Zhang, P. Y., Gao, W., Yu, J. & Robson, S. C. Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia. Front. Oncol. 13, 1244280. https:\/\/doi.org\/10.3389\/fonc.2023.1244280 (2023).","journal-title":"Front. Oncol."},{"key":"39624_CR18","doi-asserted-by":"publisher","first-page":"e79940","DOI":"10.7554\/eLife.79940","volume":"11","author":"HJ Park","year":"2022","unstructured":"Park, H. J. et al. Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM\/mTOR pathway regulating oxidative phosphorylation. Elife 11, e79940. https:\/\/doi.org\/10.7554\/eLife.79940 (2022).","journal-title":"Elife"},{"key":"39624_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol."},{"key":"39624_CR20","doi-asserted-by":"publisher","first-page":"W191","DOI":"10.1093\/nar\/gkz369","volume":"47","author":"U Raudvere","year":"2019","unstructured":"Raudvere, U. et al. g:Profiler: A web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucl. Acids Res. 47, W191\u2013W198. https:\/\/doi.org\/10.1093\/nar\/gkz369 (2019).","journal-title":"Nucl. Acids Res."},{"key":"39624_CR21","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucl. Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucl. Acids Res."},{"key":"39624_CR22","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic, M. et al. The reactome pathway knowledgebase 2024. Nucl. Acids Res. 52, D672\u2013D678. https:\/\/doi.org\/10.1093\/nar\/gkad1025 (2024).","journal-title":"Nucl. Acids Res."},{"key":"39624_CR23","doi-asserted-by":"publisher","first-page":"D679","DOI":"10.1093\/nar\/gkad960","volume":"52","author":"A Agrawal","year":"2024","unstructured":"Agrawal, A. et al. WikiPathways 2024: Next generation pathway database. Nucl. Acids Res. 52, D679\u2013D689. https:\/\/doi.org\/10.1093\/nar\/gkad960 (2024).","journal-title":"Nucl. Acids Res."},{"key":"39624_CR24","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1093\/nar\/gnf067","volume":"30","author":"L He","year":"2002","unstructured":"He, L. et al. Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR. Nucl. Acids Res. 30, e68. https:\/\/doi.org\/10.1093\/nar\/gnf067 (2002).","journal-title":"Nucl. Acids Res."},{"key":"39624_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.cell.2011.12.017","volume":"148","author":"WA Freed-Pastor","year":"2012","unstructured":"Freed-Pastor, W. A. et al. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell 148, 244\u2013258. https:\/\/doi.org\/10.1016\/j.cell.2011.12.017 (2012).","journal-title":"Cell"},{"key":"39624_CR26","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/sj.bjc.6605007","volume":"100","author":"T Mashima","year":"2009","unstructured":"Mashima, T., Seimiya, H. & Tsuruo, T. D. novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br. J. Cancer 100, 1369\u20131372. https:\/\/doi.org\/10.1038\/sj.bjc.6605007 (2009).","journal-title":"Br. J. Cancer"},{"key":"39624_CR27","doi-asserted-by":"publisher","first-page":"605154","DOI":"10.3389\/fonc.2020.605154","volume":"10","author":"W Wang","year":"2020","unstructured":"Wang, W., Bai, L., Li, W. & Cui, J. The lipid metabolic landscape of cancers and new therapeutic perspectives. Front. Oncol. 10, 605154. https:\/\/doi.org\/10.3389\/fonc.2020.605154 (2020).","journal-title":"Front. Oncol."},{"key":"39624_CR28","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1182\/blood-2004-01-0395","volume":"104","author":"DE Banker","year":"2004","unstructured":"Banker, D. E. et al. Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells. Blood 104, 1816\u20131824. https:\/\/doi.org\/10.1182\/blood-2004-01-0395 (2004).","journal-title":"Blood"},{"key":"39624_CR29","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1182\/blood-2002-07-2283","volume":"101","author":"HY Li","year":"2003","unstructured":"Li, H. Y., Appelbaum, F. R., Willman, C. L., Zager, R. A. & Banker, D. E. Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses. Blood 101, 3628\u20133634. https:\/\/doi.org\/10.1182\/blood-2002-07-2283 (2003).","journal-title":"Blood"},{"key":"39624_CR30","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/sj.leu.2401856","volume":"14","author":"L Maksumova","year":"2000","unstructured":"Maksumova, L. et al. Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin. Leukemia 14, 1444\u20131450. https:\/\/doi.org\/10.1038\/sj.leu.2401856 (2000).","journal-title":"Leukemia"},{"key":"39624_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/BS9.0000000000000016","volume":"1","author":"L Zhao","year":"2019","unstructured":"Zhao, L., Zhan, H., Jiang, X., Li, Y. & Zeng, H. The role of cholesterol metabolism in leukemia. Blood Sci 1, 44\u201349. https:\/\/doi.org\/10.1097\/BS9.0000000000000016 (2019).","journal-title":"Blood Sci"},{"key":"39624_CR32","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1126\/science.1189862","volume":"328","author":"KJ Rayner","year":"2010","unstructured":"Rayner, K. J. et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328, 1570\u20131573. https:\/\/doi.org\/10.1126\/science.1189862 (2010).","journal-title":"Science"},{"key":"39624_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41423-021-00827-0","volume":"19","author":"MS Lee","year":"2022","unstructured":"Lee, M. S. & Bensinger, S. J. Reprogramming cholesterol metabolism in macrophages and its role in host defense against cholesterol-dependent cytolysins. Cell Mol. Immunol. 19, 327\u2013336. https:\/\/doi.org\/10.1038\/s41423-021-00827-0 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"39624_CR34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cmet.2010.04.006","volume":"11","author":"KA Smoak","year":"2010","unstructured":"Smoak, K. A. et al. Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation. Cell Metab. 11, 493\u2013502. https:\/\/doi.org\/10.1016\/j.cmet.2010.04.006 (2010).","journal-title":"Cell Metab."},{"key":"39624_CR35","doi-asserted-by":"publisher","first-page":"e138539","DOI":"10.1172\/jci.insight.138539","volume":"7","author":"S Hayakawa","year":"2022","unstructured":"Hayakawa, S. et al. Activated cholesterol metabolism is integral for innate macrophage responses by amplifying Myd88 signaling. JCI Insight 7, e138539. https:\/\/doi.org\/10.1172\/jci.insight.138539 (2022).","journal-title":"JCI Insight"},{"key":"39624_CR36","doi-asserted-by":"publisher","first-page":"750271","DOI":"10.3389\/fcell.2021.750271","volume":"9","author":"Q Wang","year":"2021","unstructured":"Wang, Q. et al. Tlr2\/4 double knockout attenuates the degeneration of primary auditory neurons: Potential mechanisms from transcriptomic perspectives. Front. Cell Dev. Biol. 9, 750271. https:\/\/doi.org\/10.3389\/fcell.2021.750271 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"39624_CR37","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1182\/bloodadvances.2025017018","volume":"9","author":"ME Lawler","year":"2025","unstructured":"Lawler, M. E. et al. TLR2 agonism suppresses myeloid leukemogenesis by reprogramming leukemia stem cells. Blood Adv. 9, 5888\u20135901. https:\/\/doi.org\/10.1182\/bloodadvances.2025017018 (2025).","journal-title":"Blood Adv."},{"key":"39624_CR38","first-page":"436","volume":"47","author":"K Suzuki","year":"2017","unstructured":"Suzuki, K., Kawakami, Y. & Yamauchi, K. Impact of TLR 2, TLR 4-activation on the expression of ABCA1 and ABCG1 in raw cells. Ann. Clin. Lab. Sci. 47, 436\u2013446 (2017).","journal-title":"Ann. Clin. Lab. Sci."},{"key":"39624_CR39","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.3390\/ijms25126808","volume":"25","author":"J Kim","year":"2024","unstructured":"Kim, J. et al. Inhibition of toll-like receptors alters macrophage cholesterol efflux and foam cell formation. Int. J. Mol. Sci. 25, 6808. https:\/\/doi.org\/10.3390\/ijms25126808 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"39624_CR40","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s12672-025-02430-5","volume":"16","author":"Z Chu","year":"2025","unstructured":"Chu, Z., Fang, L., Xiang, Y. & Ding, Y. Research progress on cholesterol metabolism and tumor therapy. Discov. Oncol. 16, 647. https:\/\/doi.org\/10.1007\/s12672-025-02430-5 (2025).","journal-title":"Discov. Oncol."},{"key":"39624_CR41","doi-asserted-by":"publisher","first-page":"430","DOI":"10.20517\/cdr.2023.20","volume":"6","author":"G Jansen","year":"2023","unstructured":"Jansen, G. et al. Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cells. Cancer Drug Resist. 6, 430\u2013446. https:\/\/doi.org\/10.20517\/cdr.2023.20 (2023).","journal-title":"Cancer Drug Resist."},{"key":"39624_CR42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1080\/10428190701760011","volume":"49","author":"LP Burke","year":"2008","unstructured":"Burke, L. P. & Kukoly, C. A. Statins induce lethal effects in acute myeloblastic leukemia [corrected] cells within 72 hours. Leuk Lymphoma 49, 322\u2013330. https:\/\/doi.org\/10.1080\/10428190701760011 (2008).","journal-title":"Leuk Lymphoma"},{"key":"39624_CR43","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1073\/pnas.061038798","volume":"98","author":"J Wang","year":"2001","unstructured":"Wang, J., Silva, J. P., Gustafsson, C. M., Rustin, P. & Larsson, N. G. Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proc. Natl. Acad Sci. U S A 98, 4038\u20134043. https:\/\/doi.org\/10.1073\/pnas.061038798 (2001).","journal-title":"Proc. Natl. Acad Sci. U S A"},{"key":"39624_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000028359","volume":"60","author":"LD DeLeve","year":"2000","unstructured":"DeLeve, L. D. & Wang, X. Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes. Pharmacology 60, 143\u2013154. https:\/\/doi.org\/10.1159\/000028359 (2000).","journal-title":"Pharmacology"},{"key":"39624_CR45","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/sj.leu.2402193","volume":"15","author":"Z Hassan","year":"2001","unstructured":"Hassan, Z., Hassan, M. & Hellstrom-Lindberg, E. The pharmacodynamic effect of busulfan in the P39 myeloid cell line in vitro. Leukemia 15, 1240\u20131247. https:\/\/doi.org\/10.1038\/sj.leu.2402193 (2001).","journal-title":"Leukemia"},{"key":"39624_CR46","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.bbmt.2016.06.006","volume":"22","author":"J Qiao","year":"2016","unstructured":"Qiao, J. et al. Busulfan triggers intrinsic mitochondrial-dependent platelet apoptosis independent of platelet activation. Biol. Blood Marrow Transplant. 22, 1565\u20131572. https:\/\/doi.org\/10.1016\/j.bbmt.2016.06.006 (2016).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"39624_CR47","doi-asserted-by":"publisher","first-page":"102340","DOI":"10.1016\/j.ctrv.2022.102340","volume":"104","author":"S Crucitta","year":"2022","unstructured":"Crucitta, S. et al. Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours. Cancer Treat. Rev. 104, 102340. https:\/\/doi.org\/10.1016\/j.ctrv.2022.102340 (2022).","journal-title":"Cancer Treat. Rev."},{"key":"39624_CR48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13045-019-0818-2","volume":"12","author":"ZF Lim","year":"2019","unstructured":"Lim, Z. F. & Ma, P. C. Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy. J. Hematol. Oncol. 12, 134. https:\/\/doi.org\/10.1186\/s13045-019-0818-2 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"39624_CR49","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12935-024-03510-2","volume":"24","author":"Y Tian","year":"2024","unstructured":"Tian, Y. et al. A protracted war against cancer drug resistance. Cancer Cell Int. 24, 326. https:\/\/doi.org\/10.1186\/s12935-024-03510-2 (2024).","journal-title":"Cancer Cell Int."},{"key":"39624_CR50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2217\/pgs.13.213","volume":"15","author":"CC Brown","year":"2014","unstructured":"Brown, C. C. et al. Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell lines. Pharmacogenomics 15, 137\u2013146. https:\/\/doi.org\/10.2217\/pgs.13.213 (2014).","journal-title":"Pharmacogenomics"},{"key":"39624_CR51","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/2159-8290.CD-19-0117","volume":"9","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. Targeting mitochondrial structure sensitizes acute myeloid leukemia to venetoclax treatment. Cancer Discov. 9, 890\u2013909. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0117 (2019).","journal-title":"Cancer Discov."},{"key":"39624_CR52","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/cells8030275","volume":"8","author":"D Yang","year":"2019","unstructured":"Yang, D. & Kim, J. mitochondrial retrograde signalling and metabolic alterations in the tumour microenvironment. Cells 8, 275. https:\/\/doi.org\/10.3390\/cells8030275 (2019).","journal-title":"Cells"},{"key":"39624_CR53","doi-asserted-by":"publisher","first-page":"482582","DOI":"10.1155\/2015\/482582","volume":"2015","author":"FM da Cunha","year":"2015","unstructured":"da Cunha, F. M., Torelli, N. Q. & Kowaltowski, A. J. Mitochondrial retrograde signaling: Triggers, pathways, and outcomes. Oxid. Med. Cell Longev 2015, 482582. https:\/\/doi.org\/10.1155\/2015\/482582 (2015).","journal-title":"Oxid. Med. Cell Longev"},{"key":"39624_CR54","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.bbagen.2011.08.017","volume":"652\u2013662","author":"CC Cook","year":"1820","unstructured":"Cook, C. C. & Higuchi, M. The awakening of an advanced malignant cancer: An insult to the mitochondrial genome. Biochim. Biophys. Acta. 652\u2013662, 2012. https:\/\/doi.org\/10.1016\/j.bbagen.2011.08.017 (1820).","journal-title":"Biochim. Biophys. Acta."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39624-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39624-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39624-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T09:31:02Z","timestamp":1774603862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39624-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39624"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39624-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10213"}}